Skip to content
VMDViemed Healthcare, Inc.

Earnings

When Viemed Healthcare, Inc. reports, what it reported each quarter, and how the stock took the results.

35 quarters. Mar 31, 2018 to Sep 30, 2026. USD.

Next results · Q4 2026Projected

Mar 3, after the close

Wed, Mar 3, 2027in 105 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Mar 1 – 10

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
$76.18M
Revenue, change from a year earlier: Q3 2026 +12.2%, Q2 2026 +23.9%, Q1 2026 +27.5%, Q4 2025 +25.5%
Net income
$5.64M
Net income, change from a year earlier: Q3 2026 +32.0%, Q2 2026 −12.4%, Q1 2026 −1.6%, Q4 2025 +30.7%
EPS
—
EPS, change from a year earlier: Q3 2026 +22.2%, Q2 2026 −12.5%, Q1 2026 ±0.0%, Q3 2025 −10.0%

Quarter by quarter

Q3 2026$80.67M+12.2% vs Q3 2025

Latest results

  1. Q3 2026Nov 4, 2026, after the closeThe release10.7%by the close of Nov 5
    Revenue
    $80.67M
    +12.2%
    Net income
    $4.64M
    +32.0%
    EPS
    $0.11
    +22.2%
  2. Q2 2026Aug 3, 2026, after the closeThe release15.8%by the close of Aug 4
    Revenue
    $78.10M
    +23.9%
    Net income
    $2.76M
    −12.4%
    EPS
    $0.07
    −12.5%
  3. Q1 2026May 5, 2026, after the closeThe release12.4%by the close of May 6
    Revenue
    $75.41M
    +27.5%
    Net income
    $2.58M
    −1.6%
    EPS
    $0.06
    ±0.0%
  4. Q4 2025Mar 4, 2026, after the closeThe release7.3%by the close of Mar 5
    Revenue
    $76.18M
    +25.5%
    Net income
    $5.64M
    +30.7%
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 4, 2026 · after-hoursNov 4, 202635 d10-Q$80.67M+12.2%$0.1110.7%
Q2 2026Jun 30, 2026Aug 3, 2026 · after-hoursAug 3, 202634 d10-Q$78.10M+23.9%$0.0715.8%
Q1 2026Mar 31, 2026May 5, 2026 · after-hoursMay 5, 202635 d10-Q$75.41M+27.5%$0.0612.4%
FY 2025
Q4 2025derivedDec 31, 2025Mar 4, 2026 · after-hoursMar 4, 202663 d10-K$76.18M+25.5%—7.3%
Q3 2025Sep 30, 2025Nov 5, 2025 · after-hoursNov 5, 202536 d10-Q$71.91M+24.0%$0.092.3%
Q2 2025Jun 30, 2025Aug 6, 2025 · after-hoursAug 6, 202537 d10-Q$63.06M+14.7%$0.08+7.7%
Q1 2025Mar 31, 2025May 7, 2025 · after-hoursMay 7, 202537 d10-Q$59.13M+16.9%$0.0611.6%
FY 2024
Q4 2024derivedDec 31, 2024Mar 10, 2025 · after-hoursMar 10, 202569 d10-K$60.70M+19.6%—+5.4%
Q3 2024Sep 30, 2024Nov 6, 2024 · after-hoursNov 6, 202437 d10-Q$58.00M+17.4%$0.101.5%
Q2 2024Jun 30, 2024Aug 7, 2024 · after-hoursAug 7, 202438 d10-Q$54.97M+26.9%$0.04—
Q1 2024Mar 31, 2024May 6, 2024 · after-hoursMay 6, 202436 d10-Q$50.59M+27.9%$0.0414.4%
Earlier years, FY 2018 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 4, 2026000056
10-QAug 3, 2026000042
10-QMay 5, 2026000029
10-KMar 4, 2026000009
10-QNov 5, 2025000149
10-QAug 6, 2025000119
10-QMay 7, 2025000096
10-KMar 10, 2025000056
10-QNov 6, 2024000210
10-QAug 7, 2024000162

Provenance

ProvenanceData status and checks

Viemed Healthcare, Inc. · CIK 1729149 · Engraved from SEC EDGAR